Pricing Log in Create free account

PMV Pharmaceuticals, Inc. (PMVP) vs Retension Pharmaceuticals, Inc. (RTSN)

PMV Pharmaceuticals, Inc. and Retension Pharmaceuticals, Inc. are both Biotechnology companies. PMV Pharmaceuticals, Inc. and Retension Pharmaceuticals, Inc. are of similar size ($100.1M and $96.6M).

Valuation

Metric PMVP RTSN Biotechnology median
P/E n/m — 10.26
P/S n/m — 9.18
P/B 0.94 — 2.05
Price to free cash flow n/m — 24.81
EV/EBITDA 0.15 — 0.65
EV/Sales n/m — 8.98
Earnings yield (112.70%) — (34.89%)
Free cash flow yield (105.94%) — (24.52%)

Profitability

Metric PMVP RTSN Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity (70.93%) — (50.12%)
Return on assets (64.04%) — (45.60%)
Return on invested capital 0.00% — 0.00%

Growth

Metric PMVP RTSN Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) (29.82%) — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric PMVP RTSN Biotechnology median
Debt to equity 0.00 — 0.00
Current ratio 7.70 — 4.89
Net debt to EBITDA 1.27 — 1.01

Dividend

Metric PMVP RTSN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PMVP RTSN Biotechnology median
Market cap 100.06m 96.61m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack